Related Experiment Videos
Evaluation of constitutional chromosome aberrations in hematologic disorders
Roxana Cerretini1, Susana Acevedo, Christian Chena
1Departmento de Genética, Instituto de Investigaciones Hematológicas Mariano R. Castex, Academia Nacional de Medicina, Pacheco de Melo 3081, 1425, Buenos Aires, Argentina. lacuteci@intramed.net.ar
Cancer Genetics and Cytogenetics
|May 30, 2002
Summary
Constitutional chromosome aberrations (CCA) are rare in hematologic patients. Except for Down syndrome, CCA do not increase the risk of developing hematologic malignancies.
Area of Science:
- Cytogenetics
- Hematology
- Medical Genetics
Background:
- Constitutional chromosome aberrations (CCA) are genetic alterations present from birth.
- Understanding the frequency and impact of CCA in hematologic disorders is crucial for patient management and risk assessment.
Purpose of the Study:
- To determine the frequency of CCA in a large cohort of patients with hematologic disorders.
- To evaluate the association between CCA and the development of hematologic malignancies.
Main Methods:
- Retrospective review of cytogenetic data from 4164 patients with hematologic disorders over 25 years.
- Analysis of CCA types, including translocations, sex chromosome abnormalities, and Down syndrome (DS).
- Comparison of CCA frequencies in the patient cohort with population-based birth data.
Main Results:
- Twenty-four (0.58%) patients had CCA, including Robertsonian translocations, balanced translocations, sex chromosome abnormalities, and Down syndrome.
- The incidence of Down syndrome in the hematologic patient cohort was significantly higher than in the general population.
- The overall incidence of CCA, excluding Down syndrome, was lower in hematologic patients compared to the general population.
Conclusions:
- Constitutional chromosome aberrations are infrequent in patients with hematologic disorders.
- Down syndrome occurs more frequently in patients with hematologic disorders than in the general population.
- The presence of CCA, other than Down syndrome, does not appear to predispose individuals to hematologic malignancies.